instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nausea'. | Safety of switching between rituximab biosimilars in onco-hematology.
Comparable clinical efficacy and safety of the reference rituximab (MABTHERA) and its biosimilars has been established in randomized trials. However, safety concerns are often raised when switching from reference to biosimilar products and between di... | RITUXIMAB-ABBS | DrugsGivenReaction | CC BY | 33727667 | 19,187,223 | 2021-03-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neutropenia'. | Safety of switching between rituximab biosimilars in onco-hematology.
Comparable clinical efficacy and safety of the reference rituximab (MABTHERA) and its biosimilars has been established in randomized trials. However, safety concerns are often raised when switching from reference to biosimilar products and between di... | RITUXIMAB-ABBS | DrugsGivenReaction | CC BY | 33727667 | 19,187,223 | 2021-03-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Paraesthesia'. | Safety of switching between rituximab biosimilars in onco-hematology.
Comparable clinical efficacy and safety of the reference rituximab (MABTHERA) and its biosimilars has been established in randomized trials. However, safety concerns are often raised when switching from reference to biosimilar products and between di... | RITUXIMAB-ABBS | DrugsGivenReaction | CC BY | 33727667 | 19,187,223 | 2021-03-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pyrexia'. | Safety of switching between rituximab biosimilars in onco-hematology.
Comparable clinical efficacy and safety of the reference rituximab (MABTHERA) and its biosimilars has been established in randomized trials. However, safety concerns are often raised when switching from reference to biosimilar products and between di... | RITUXIMAB-ABBS | DrugsGivenReaction | CC BY | 33727667 | 19,187,223 | 2021-03-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rash'. | Safety of switching between rituximab biosimilars in onco-hematology.
Comparable clinical efficacy and safety of the reference rituximab (MABTHERA) and its biosimilars has been established in randomized trials. However, safety concerns are often raised when switching from reference to biosimilar products and between di... | RITUXIMAB-ABBS | DrugsGivenReaction | CC BY | 33727667 | 19,187,223 | 2021-03-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy partial responder'. | Safety of switching between rituximab biosimilars in onco-hematology.
Comparable clinical efficacy and safety of the reference rituximab (MABTHERA) and its biosimilars has been established in randomized trials. However, safety concerns are often raised when switching from reference to biosimilar products and between di... | RITUXIMAB-ABBS | DrugsGivenReaction | CC BY | 33727667 | 19,187,223 | 2021-03-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Throat irritation'. | Safety of switching between rituximab biosimilars in onco-hematology.
Comparable clinical efficacy and safety of the reference rituximab (MABTHERA) and its biosimilars has been established in randomized trials. However, safety concerns are often raised when switching from reference to biosimilar products and between di... | RITUXIMAB-ABBS | DrugsGivenReaction | CC BY | 33727667 | 19,187,223 | 2021-03-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thrombocytopenia'. | Safety of switching between rituximab biosimilars in onco-hematology.
Comparable clinical efficacy and safety of the reference rituximab (MABTHERA) and its biosimilars has been established in randomized trials. However, safety concerns are often raised when switching from reference to biosimilar products and between di... | RITUXIMAB-ABBS | DrugsGivenReaction | CC BY | 33727667 | 19,187,223 | 2021-03-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tremor'. | Safety of switching between rituximab biosimilars in onco-hematology.
Comparable clinical efficacy and safety of the reference rituximab (MABTHERA) and its biosimilars has been established in randomized trials. However, safety concerns are often raised when switching from reference to biosimilar products and between di... | RITUXIMAB-ABBS | DrugsGivenReaction | CC BY | 33727667 | 19,187,223 | 2021-03-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Urinary tract infection'. | Safety of switching between rituximab biosimilars in onco-hematology.
Comparable clinical efficacy and safety of the reference rituximab (MABTHERA) and its biosimilars has been established in randomized trials. However, safety concerns are often raised when switching from reference to biosimilar products and between di... | RITUXIMAB-ABBS | DrugsGivenReaction | CC BY | 33727667 | 19,187,223 | 2021-03-16 |
What was the dosage of drug 'RITUXIMAB-ABBS'? | Safety of switching between rituximab biosimilars in onco-hematology.
Comparable clinical efficacy and safety of the reference rituximab (MABTHERA) and its biosimilars has been established in randomized trials. However, safety concerns are often raised when switching from reference to biosimilar products and between di... | 375 MG/M2 | DrugDosageText | CC BY | 33727667 | 19,187,223 | 2021-03-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Ayurveda co-interventions have supported complete recovery in Severe COVID- 19 infection with a Chest Severity Score 18/25: A Case Report.
Severe COVID-19 infection requiring oxygen support is reported to have high mortality. Chest Severity Score evaluated through CT scan has a predictive value about future outcomes in... | ASPIRIN, AZITHROMYCIN, FAVIPIRAVIR | DrugsGivenReaction | CC BY-NC-ND | 33727768 | 20,805,418 | 2021-03-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Ayurveda co-interventions have supported complete recovery in Severe COVID- 19 infection with a Chest Severity Score 18/25: A Case Report.
Severe COVID-19 infection requiring oxygen support is reported to have high mortality. Chest Severity Score evaluated through CT scan has a predictive value about future outcomes in... | ASPIRIN, AZITHROMYCIN, BLACK PEPPER, FAVIPIRAVIR | DrugsGivenReaction | CC BY-NC-ND | 33727768 | 20,802,296 | 2021-03-12 |
What was the dosage of drug 'ASPIRIN'? | Ayurveda co-interventions have supported complete recovery in Severe COVID- 19 infection with a Chest Severity Score 18/25: A Case Report.
Severe COVID-19 infection requiring oxygen support is reported to have high mortality. Chest Severity Score evaluated through CT scan has a predictive value about future outcomes in... | UNK (LOW DOSE) | DrugDosageText | CC BY-NC-ND | 33727768 | 20,802,296 | 2021-03-12 |
What was the dosage of drug 'BLACK PEPPER'? | Ayurveda co-interventions have supported complete recovery in Severe COVID- 19 infection with a Chest Severity Score 18/25: A Case Report.
Severe COVID-19 infection requiring oxygen support is reported to have high mortality. Chest Severity Score evaluated through CT scan has a predictive value about future outcomes in... | 500 MG | DrugDosageText | CC BY-NC-ND | 33727768 | 20,802,296 | 2021-03-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac dysfunction'. | Refractory Acute Interstitial Nephritis in the Setting of Nivolumab Therapy.
A 65-year-old male patient with metastatic CCRCC developed steroid-dependent, grade 3 AIN secondary to nivolumab weeks after its initiation that resulted in 3 hospitalizations with acute renal failure. The patient was started on MM and his AIN... | CEPHALEXIN, FUROSEMIDE, METHYLPREDNISOLONE, NIVOLUMAB, OMEPRAZOLE, PREDNISONE | DrugsGivenReaction | CC BY | 33728076 | 19,201,282 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Refractory Acute Interstitial Nephritis in the Setting of Nivolumab Therapy.
A 65-year-old male patient with metastatic CCRCC developed steroid-dependent, grade 3 AIN secondary to nivolumab weeks after its initiation that resulted in 3 hospitalizations with acute renal failure. The patient was started on MM and his AIN... | FUROSEMIDE | DrugsGivenReaction | CC BY | 33728076 | 19,187,754 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug dependence'. | Refractory Acute Interstitial Nephritis in the Setting of Nivolumab Therapy.
A 65-year-old male patient with metastatic CCRCC developed steroid-dependent, grade 3 AIN secondary to nivolumab weeks after its initiation that resulted in 3 hospitalizations with acute renal failure. The patient was started on MM and his AIN... | FUROSEMIDE, METHYLPREDNISOLONE SODIUM SUCCINATE, MYCOPHENOLATE MOFETIL, PREDNISONE | DrugsGivenReaction | CC BY | 33728076 | 19,158,756 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Refractory Acute Interstitial Nephritis in the Setting of Nivolumab Therapy.
A 65-year-old male patient with metastatic CCRCC developed steroid-dependent, grade 3 AIN secondary to nivolumab weeks after its initiation that resulted in 3 hospitalizations with acute renal failure. The patient was started on MM and his AIN... | CEPHALEXIN, FUROSEMIDE, METHYLPREDNISOLONE, NIVOLUMAB, OMEPRAZOLE, PREDNISONE | DrugsGivenReaction | CC BY | 33728076 | 19,201,282 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Electrocardiogram T wave peaked'. | Refractory Acute Interstitial Nephritis in the Setting of Nivolumab Therapy.
A 65-year-old male patient with metastatic CCRCC developed steroid-dependent, grade 3 AIN secondary to nivolumab weeks after its initiation that resulted in 3 hospitalizations with acute renal failure. The patient was started on MM and his AIN... | CEPHALEXIN, FUROSEMIDE, METHYLPREDNISOLONE, NIVOLUMAB, OMEPRAZOLE, PREDNISONE | DrugsGivenReaction | CC BY | 33728076 | 19,201,282 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyperkalaemia'. | Refractory Acute Interstitial Nephritis in the Setting of Nivolumab Therapy.
A 65-year-old male patient with metastatic CCRCC developed steroid-dependent, grade 3 AIN secondary to nivolumab weeks after its initiation that resulted in 3 hospitalizations with acute renal failure. The patient was started on MM and his AIN... | CEPHALEXIN, FUROSEMIDE, METHYLPREDNISOLONE, NIVOLUMAB, OMEPRAZOLE, PREDNISONE | DrugsGivenReaction | CC BY | 33728076 | 19,201,282 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metabolic acidosis'. | Refractory Acute Interstitial Nephritis in the Setting of Nivolumab Therapy.
A 65-year-old male patient with metastatic CCRCC developed steroid-dependent, grade 3 AIN secondary to nivolumab weeks after its initiation that resulted in 3 hospitalizations with acute renal failure. The patient was started on MM and his AIN... | CEPHALEXIN, FUROSEMIDE, METHYLPREDNISOLONE, NIVOLUMAB, OMEPRAZOLE, PREDNISONE | DrugsGivenReaction | CC BY | 33728076 | 19,201,282 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pleural effusion'. | Refractory Acute Interstitial Nephritis in the Setting of Nivolumab Therapy.
A 65-year-old male patient with metastatic CCRCC developed steroid-dependent, grade 3 AIN secondary to nivolumab weeks after its initiation that resulted in 3 hospitalizations with acute renal failure. The patient was started on MM and his AIN... | CEPHALEXIN, FUROSEMIDE, METHYLPREDNISOLONE, NIVOLUMAB, OMEPRAZOLE, PREDNISONE | DrugsGivenReaction | CC BY | 33728076 | 19,201,282 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pulmonary congestion'. | Refractory Acute Interstitial Nephritis in the Setting of Nivolumab Therapy.
A 65-year-old male patient with metastatic CCRCC developed steroid-dependent, grade 3 AIN secondary to nivolumab weeks after its initiation that resulted in 3 hospitalizations with acute renal failure. The patient was started on MM and his AIN... | CEPHALEXIN, FUROSEMIDE, METHYLPREDNISOLONE, NIVOLUMAB, OMEPRAZOLE, PREDNISONE | DrugsGivenReaction | CC BY | 33728076 | 19,201,282 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renal tubular injury'. | Refractory Acute Interstitial Nephritis in the Setting of Nivolumab Therapy.
A 65-year-old male patient with metastatic CCRCC developed steroid-dependent, grade 3 AIN secondary to nivolumab weeks after its initiation that resulted in 3 hospitalizations with acute renal failure. The patient was started on MM and his AIN... | CEPHALEXIN, FUROSEMIDE, METHYLPREDNISOLONE, NIVOLUMAB, OMEPRAZOLE, PREDNISONE | DrugsGivenReaction | CC BY | 33728076 | 19,201,282 | 2021 |
What was the administration route of drug 'METHYLPREDNISOLONE SODIUM SUCCINATE'? | Refractory Acute Interstitial Nephritis in the Setting of Nivolumab Therapy.
A 65-year-old male patient with metastatic CCRCC developed steroid-dependent, grade 3 AIN secondary to nivolumab weeks after its initiation that resulted in 3 hospitalizations with acute renal failure. The patient was started on MM and his AIN... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33728076 | 19,158,756 | 2021 |
What was the administration route of drug 'METHYLPREDNISOLONE'? | Refractory Acute Interstitial Nephritis in the Setting of Nivolumab Therapy.
A 65-year-old male patient with metastatic CCRCC developed steroid-dependent, grade 3 AIN secondary to nivolumab weeks after its initiation that resulted in 3 hospitalizations with acute renal failure. The patient was started on MM and his AIN... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33728076 | 19,201,282 | 2021 |
What was the administration route of drug 'PREDNISONE'? | Refractory Acute Interstitial Nephritis in the Setting of Nivolumab Therapy.
A 65-year-old male patient with metastatic CCRCC developed steroid-dependent, grade 3 AIN secondary to nivolumab weeks after its initiation that resulted in 3 hospitalizations with acute renal failure. The patient was started on MM and his AIN... | Oral | DrugAdministrationRoute | CC BY | 33728076 | 19,158,756 | 2021 |
What was the dosage of drug 'FUROSEMIDE'? | Refractory Acute Interstitial Nephritis in the Setting of Nivolumab Therapy.
A 65-year-old male patient with metastatic CCRCC developed steroid-dependent, grade 3 AIN secondary to nivolumab weeks after its initiation that resulted in 3 hospitalizations with acute renal failure. The patient was started on MM and his AIN... | UNKNOWN | DrugDosageText | CC BY | 33728076 | 19,232,099 | 2021 |
What was the outcome of reaction 'Cardiac dysfunction'? | Refractory Acute Interstitial Nephritis in the Setting of Nivolumab Therapy.
A 65-year-old male patient with metastatic CCRCC developed steroid-dependent, grade 3 AIN secondary to nivolumab weeks after its initiation that resulted in 3 hospitalizations with acute renal failure. The patient was started on MM and his AIN... | Recovered | ReactionOutcome | CC BY | 33728076 | 19,201,282 | 2021 |
What was the outcome of reaction 'Electrocardiogram T wave peaked'? | Refractory Acute Interstitial Nephritis in the Setting of Nivolumab Therapy.
A 65-year-old male patient with metastatic CCRCC developed steroid-dependent, grade 3 AIN secondary to nivolumab weeks after its initiation that resulted in 3 hospitalizations with acute renal failure. The patient was started on MM and his AIN... | Recovered | ReactionOutcome | CC BY | 33728076 | 19,201,282 | 2021 |
What was the outcome of reaction 'Hyperkalaemia'? | Refractory Acute Interstitial Nephritis in the Setting of Nivolumab Therapy.
A 65-year-old male patient with metastatic CCRCC developed steroid-dependent, grade 3 AIN secondary to nivolumab weeks after its initiation that resulted in 3 hospitalizations with acute renal failure. The patient was started on MM and his AIN... | Recovered | ReactionOutcome | CC BY | 33728076 | 19,201,282 | 2021 |
What was the outcome of reaction 'Metabolic acidosis'? | Refractory Acute Interstitial Nephritis in the Setting of Nivolumab Therapy.
A 65-year-old male patient with metastatic CCRCC developed steroid-dependent, grade 3 AIN secondary to nivolumab weeks after its initiation that resulted in 3 hospitalizations with acute renal failure. The patient was started on MM and his AIN... | Recovered | ReactionOutcome | CC BY | 33728076 | 19,201,282 | 2021 |
What was the outcome of reaction 'Pleural effusion'? | Refractory Acute Interstitial Nephritis in the Setting of Nivolumab Therapy.
A 65-year-old male patient with metastatic CCRCC developed steroid-dependent, grade 3 AIN secondary to nivolumab weeks after its initiation that resulted in 3 hospitalizations with acute renal failure. The patient was started on MM and his AIN... | Recovered | ReactionOutcome | CC BY | 33728076 | 19,201,282 | 2021 |
What was the outcome of reaction 'Pulmonary congestion'? | Refractory Acute Interstitial Nephritis in the Setting of Nivolumab Therapy.
A 65-year-old male patient with metastatic CCRCC developed steroid-dependent, grade 3 AIN secondary to nivolumab weeks after its initiation that resulted in 3 hospitalizations with acute renal failure. The patient was started on MM and his AIN... | Recovered | ReactionOutcome | CC BY | 33728076 | 19,201,282 | 2021 |
What was the outcome of reaction 'Renal tubular injury'? | Refractory Acute Interstitial Nephritis in the Setting of Nivolumab Therapy.
A 65-year-old male patient with metastatic CCRCC developed steroid-dependent, grade 3 AIN secondary to nivolumab weeks after its initiation that resulted in 3 hospitalizations with acute renal failure. The patient was started on MM and his AIN... | Recovered | ReactionOutcome | CC BY | 33728076 | 19,201,282 | 2021 |
What was the outcome of reaction 'Steroid dependence'? | Refractory Acute Interstitial Nephritis in the Setting of Nivolumab Therapy.
A 65-year-old male patient with metastatic CCRCC developed steroid-dependent, grade 3 AIN secondary to nivolumab weeks after its initiation that resulted in 3 hospitalizations with acute renal failure. The patient was started on MM and his AIN... | Recovering | ReactionOutcome | CC BY | 33728076 | 19,232,099 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Basal cell carcinoma'. | Development of Two Types of Skin Cancer in a Patient with Systemic Sclerosis: a Case Report and Overview of the Literature.
Systemic sclerosis (SSc) is an uncommon rheumatic disease in which the underlying main histopathologic feature is a thickening of the skin due to excessive accumulation of collagen in the extracel... | CYCLOPHOSPHAMIDE, RITUXIMAB | DrugsGivenReaction | CC BY | 33728079 | 19,065,205 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Squamous cell carcinoma'. | Development of Two Types of Skin Cancer in a Patient with Systemic Sclerosis: a Case Report and Overview of the Literature.
Systemic sclerosis (SSc) is an uncommon rheumatic disease in which the underlying main histopathologic feature is a thickening of the skin due to excessive accumulation of collagen in the extracel... | CYCLOPHOSPHAMIDE, RITUXIMAB | DrugsGivenReaction | CC BY | 33728079 | 19,065,205 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease recurrence'. | Early Gastrointestinal Progression to Immunotherapy in Lung Cancer: A Report of Two Cases.
Intestinal and pancreatic metastases are rare and often challenging to recognize and manage. Lung cancer patients with enteric involvement usually display poor outcomes. Hyperprogression to immunotherapy represents a concern, eve... | CARBOPLATIN, CISPLATIN, PACLITAXEL, PEMETREXED, VINORELBINE TARTRATE | DrugsGivenReaction | CC BY | 33728080 | 19,198,284 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metastases to lung'. | Early Gastrointestinal Progression to Immunotherapy in Lung Cancer: A Report of Two Cases.
Intestinal and pancreatic metastases are rare and often challenging to recognize and manage. Lung cancer patients with enteric involvement usually display poor outcomes. Hyperprogression to immunotherapy represents a concern, eve... | CARBOPLATIN, CISPLATIN, PACLITAXEL, PEMETREXED, VINORELBINE TARTRATE | DrugsGivenReaction | CC BY | 33728080 | 19,198,284 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic product effect incomplete'. | Early Gastrointestinal Progression to Immunotherapy in Lung Cancer: A Report of Two Cases.
Intestinal and pancreatic metastases are rare and often challenging to recognize and manage. Lung cancer patients with enteric involvement usually display poor outcomes. Hyperprogression to immunotherapy represents a concern, eve... | CARBOPLATIN, CISPLATIN, PACLITAXEL, PEMETREXED, VINORELBINE TARTRATE | DrugsGivenReaction | CC BY | 33728080 | 19,198,284 | 2021 |
What was the administration route of drug 'PREDNISONE'? | Early Gastrointestinal Progression to Immunotherapy in Lung Cancer: A Report of Two Cases.
Intestinal and pancreatic metastases are rare and often challenging to recognize and manage. Lung cancer patients with enteric involvement usually display poor outcomes. Hyperprogression to immunotherapy represents a concern, eve... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33728080 | 19,184,707 | 2021 |
What was the dosage of drug 'CISPLATIN'? | Early Gastrointestinal Progression to Immunotherapy in Lung Cancer: A Report of Two Cases.
Intestinal and pancreatic metastases are rare and often challenging to recognize and manage. Lung cancer patients with enteric involvement usually display poor outcomes. Hyperprogression to immunotherapy represents a concern, eve... | FOUR CYCLES | DrugDosageText | CC BY | 33728080 | 19,198,284 | 2021 |
What was the dosage of drug 'PREDNISONE'? | Early Gastrointestinal Progression to Immunotherapy in Lung Cancer: A Report of Two Cases.
Intestinal and pancreatic metastases are rare and often challenging to recognize and manage. Lung cancer patients with enteric involvement usually display poor outcomes. Hyperprogression to immunotherapy represents a concern, eve... | 1 MILLIGRAM/KILOGRAM | DrugDosageText | CC BY | 33728080 | 19,184,707 | 2021 |
What was the dosage of drug 'VINORELBINE TARTRATE'? | Early Gastrointestinal Progression to Immunotherapy in Lung Cancer: A Report of Two Cases.
Intestinal and pancreatic metastases are rare and often challenging to recognize and manage. Lung cancer patients with enteric involvement usually display poor outcomes. Hyperprogression to immunotherapy represents a concern, eve... | FOUR CYCLES | DrugDosageText | CC BY | 33728080 | 19,198,284 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug intolerance'. | Chronic Serotonergic Overstimulation Mimicking Panic Attacks in a Patient with Parkinson's Disease Receiving Additional Antidepressant Treatment with Moclobemide.
The pharmacological treatment options of Parkinson's disease (PD) have considerably evolved during the last decades. However, therapeutic regimes are complic... | AGOMELATINE, BENSERAZIDE\LEVODOPA, LEVOTHYROXINE, MIRTAZAPINE, MOCLOBEMIDE, PRAMIPEXOLE, RANOLAZINE, RASAGILINE, TRAZODONE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33728085 | 19,155,273 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Chronic Serotonergic Overstimulation Mimicking Panic Attacks in a Patient with Parkinson's Disease Receiving Additional Antidepressant Treatment with Moclobemide.
The pharmacological treatment options of Parkinson's disease (PD) have considerably evolved during the last decades. However, therapeutic regimes are complic... | AGOMELATINE, BENSERAZIDE HYDROCHLORIDE\LEVODOPA, LEVOTHYROXINE, MOCLOBEMIDE, PRAMIPEXOLE, RANOLAZINE, RASAGILINE | DrugsGivenReaction | CC BY | 33728085 | 19,135,231 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Toxicity to various agents'. | Chronic Serotonergic Overstimulation Mimicking Panic Attacks in a Patient with Parkinson's Disease Receiving Additional Antidepressant Treatment with Moclobemide.
The pharmacological treatment options of Parkinson's disease (PD) have considerably evolved during the last decades. However, therapeutic regimes are complic... | AGOMELATINE, BENSERAZIDE\LEVODOPA, LEVOTHYROXINE, MIRTAZAPINE, MOCLOBEMIDE, PRAMIPEXOLE, RANOLAZINE, RASAGILINE, TRAZODONE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33728085 | 19,155,273 | 2021 |
What is the weight of the patient? | Chronic Serotonergic Overstimulation Mimicking Panic Attacks in a Patient with Parkinson's Disease Receiving Additional Antidepressant Treatment with Moclobemide.
The pharmacological treatment options of Parkinson's disease (PD) have considerably evolved during the last decades. However, therapeutic regimes are complic... | 65 kg. | Weight | CC BY | 33728085 | 19,194,247 | 2021 |
What was the administration route of drug 'ROTIGOTINE'? | Chronic Serotonergic Overstimulation Mimicking Panic Attacks in a Patient with Parkinson's Disease Receiving Additional Antidepressant Treatment with Moclobemide.
The pharmacological treatment options of Parkinson's disease (PD) have considerably evolved during the last decades. However, therapeutic regimes are complic... | Transdermal | DrugAdministrationRoute | CC BY | 33728085 | 19,194,247 | 2021 |
What was the dosage of drug 'MIRTAZAPINE'? | Chronic Serotonergic Overstimulation Mimicking Panic Attacks in a Patient with Parkinson's Disease Receiving Additional Antidepressant Treatment with Moclobemide.
The pharmacological treatment options of Parkinson's disease (PD) have considerably evolved during the last decades. However, therapeutic regimes are complic... | TREATMENT TRIAL | DrugDosageText | CC BY | 33728085 | 19,165,149 | 2021 |
What was the dosage of drug 'RANOLAZINE HYDROCHLORIDE'? | Chronic Serotonergic Overstimulation Mimicking Panic Attacks in a Patient with Parkinson's Disease Receiving Additional Antidepressant Treatment with Moclobemide.
The pharmacological treatment options of Parkinson's disease (PD) have considerably evolved during the last decades. However, therapeutic regimes are complic... | 375 mg (milligrams). | DrugDosage | CC BY | 33728085 | 19,085,716 | 2021 |
What was the dosage of drug 'RASAGILINE MESYLATE'? | Chronic Serotonergic Overstimulation Mimicking Panic Attacks in a Patient with Parkinson's Disease Receiving Additional Antidepressant Treatment with Moclobemide.
The pharmacological treatment options of Parkinson's disease (PD) have considerably evolved during the last decades. However, therapeutic regimes are complic... | 1 MILLIGRAM, QD | DrugDosageText | CC BY | 33728085 | 19,165,149 | 2021 |
What was the dosage of drug 'TRAZODONE HYDROCHLORIDE'? | Chronic Serotonergic Overstimulation Mimicking Panic Attacks in a Patient with Parkinson's Disease Receiving Additional Antidepressant Treatment with Moclobemide.
The pharmacological treatment options of Parkinson's disease (PD) have considerably evolved during the last decades. However, therapeutic regimes are complic... | TREATMENT TRIAL | DrugDosageText | CC BY | 33728085 | 19,165,149 | 2021 |
What was the outcome of reaction 'Condition aggravated'? | Chronic Serotonergic Overstimulation Mimicking Panic Attacks in a Patient with Parkinson's Disease Receiving Additional Antidepressant Treatment with Moclobemide.
The pharmacological treatment options of Parkinson's disease (PD) have considerably evolved during the last decades. However, therapeutic regimes are complic... | Recovered | ReactionOutcome | CC BY | 33728085 | 19,095,322 | 2021 |
What was the outcome of reaction 'Drug interaction'? | Chronic Serotonergic Overstimulation Mimicking Panic Attacks in a Patient with Parkinson's Disease Receiving Additional Antidepressant Treatment with Moclobemide.
The pharmacological treatment options of Parkinson's disease (PD) have considerably evolved during the last decades. However, therapeutic regimes are complic... | Recovered | ReactionOutcome | CC BY | 33728085 | 19,165,149 | 2021 |
What was the outcome of reaction 'Off label use'? | Chronic Serotonergic Overstimulation Mimicking Panic Attacks in a Patient with Parkinson's Disease Receiving Additional Antidepressant Treatment with Moclobemide.
The pharmacological treatment options of Parkinson's disease (PD) have considerably evolved during the last decades. However, therapeutic regimes are complic... | Recovered | ReactionOutcome | CC BY | 33728085 | 19,135,231 | 2021 |
What was the outcome of reaction 'Serotonin syndrome'? | Chronic Serotonergic Overstimulation Mimicking Panic Attacks in a Patient with Parkinson's Disease Receiving Additional Antidepressant Treatment with Moclobemide.
The pharmacological treatment options of Parkinson's disease (PD) have considerably evolved during the last decades. However, therapeutic regimes are complic... | Recovered | ReactionOutcome | CC BY | 33728085 | 19,165,149 | 2021 |
What was the outcome of reaction 'Toxicity to various agents'? | Chronic Serotonergic Overstimulation Mimicking Panic Attacks in a Patient with Parkinson's Disease Receiving Additional Antidepressant Treatment with Moclobemide.
The pharmacological treatment options of Parkinson's disease (PD) have considerably evolved during the last decades. However, therapeutic regimes are complic... | Recovering | ReactionOutcome | CC BY | 33728085 | 19,155,273 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bordetella infection'. | Coinfection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Bordetella bronchiseptica Pneumonia in a Renal Transplant Patient.
Bordetella species cause respiratory infections in both humans and animals. Bordetella bronchiseptica (B. bronchiseptica) infection is an uncommon pathogen in humans. The cl... | MYCOPHENOLIC ACID, PREDNISONE | DrugsGivenReaction | CC BY | 33728132 | 19,089,181 | 2021-02-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'COVID-19'. | Coinfection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Bordetella bronchiseptica Pneumonia in a Renal Transplant Patient.
Bordetella species cause respiratory infections in both humans and animals. Bordetella bronchiseptica (B. bronchiseptica) infection is an uncommon pathogen in humans. The cl... | MYCOPHENOLIC ACID, PREDNISONE | DrugsGivenReaction | CC BY | 33728132 | 19,089,181 | 2021-02-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia bacterial'. | Coinfection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Bordetella bronchiseptica Pneumonia in a Renal Transplant Patient.
Bordetella species cause respiratory infections in both humans and animals. Bordetella bronchiseptica (B. bronchiseptica) infection is an uncommon pathogen in humans. The cl... | MYCOPHENOLIC ACID, PREDNISONE | DrugsGivenReaction | CC BY | 33728132 | 19,089,181 | 2021-02-03 |
What is the weight of the patient? | Coinfection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Bordetella bronchiseptica Pneumonia in a Renal Transplant Patient.
Bordetella species cause respiratory infections in both humans and animals. Bordetella bronchiseptica (B. bronchiseptica) infection is an uncommon pathogen in humans. The cl... | 123 kg. | Weight | CC BY | 33728132 | 19,089,181 | 2021-02-03 |
What was the dosage of drug 'MYCOPHENOLIC ACID'? | Coinfection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Bordetella bronchiseptica Pneumonia in a Renal Transplant Patient.
Bordetella species cause respiratory infections in both humans and animals. Bordetella bronchiseptica (B. bronchiseptica) infection is an uncommon pathogen in humans. The cl... | 500 mg (milligrams). | DrugDosage | CC BY | 33728132 | 19,089,181 | 2021-02-03 |
What was the dosage of drug 'PREDNISONE'? | Coinfection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Bordetella bronchiseptica Pneumonia in a Renal Transplant Patient.
Bordetella species cause respiratory infections in both humans and animals. Bordetella bronchiseptica (B. bronchiseptica) infection is an uncommon pathogen in humans. The cl... | 5 mg (milligrams). | DrugDosage | CC BY | 33728132 | 19,089,181 | 2021-02-03 |
What was the outcome of reaction 'Bordetella infection'? | Coinfection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Bordetella bronchiseptica Pneumonia in a Renal Transplant Patient.
Bordetella species cause respiratory infections in both humans and animals. Bordetella bronchiseptica (B. bronchiseptica) infection is an uncommon pathogen in humans. The cl... | Recovered | ReactionOutcome | CC BY | 33728132 | 19,089,181 | 2021-02-03 |
What was the outcome of reaction 'COVID-19'? | Coinfection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Bordetella bronchiseptica Pneumonia in a Renal Transplant Patient.
Bordetella species cause respiratory infections in both humans and animals. Bordetella bronchiseptica (B. bronchiseptica) infection is an uncommon pathogen in humans. The cl... | Recovered | ReactionOutcome | CC BY | 33728132 | 19,089,181 | 2021-02-03 |
What was the outcome of reaction 'Pneumonia bacterial'? | Coinfection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Bordetella bronchiseptica Pneumonia in a Renal Transplant Patient.
Bordetella species cause respiratory infections in both humans and animals. Bordetella bronchiseptica (B. bronchiseptica) infection is an uncommon pathogen in humans. The cl... | Recovered | ReactionOutcome | CC BY | 33728132 | 19,089,181 | 2021-02-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | A Case of Metastatic Pancreatic Adenocarcinoma in Complete Remission Using Chemotherapy and Immunotherapy.
Among the various types of cancer, pancreatic cancer is considered to have a particularly grim prognosis. Treatment includes surgery, chemotherapy, or both. While the role of immunotherapy is well-studied in many ... | FLUOROURACIL, IRINOTECAN, LEUCOVORIN, OXALIPLATIN | DrugsGivenReaction | CC BY | 33728149 | 19,089,454 | 2021-02-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | A Case of Metastatic Pancreatic Adenocarcinoma in Complete Remission Using Chemotherapy and Immunotherapy.
Among the various types of cancer, pancreatic cancer is considered to have a particularly grim prognosis. Treatment includes surgery, chemotherapy, or both. While the role of immunotherapy is well-studied in many ... | FLUOROURACIL, IRINOTECAN HYDROCHLORIDE, LEUCOVORIN CALCIUM, OXALIPLATIN | DrugsGivenReaction | CC BY | 33728149 | 19,060,614 | 2021-02-04 |
What was the outcome of reaction 'Product use in unapproved indication'? | A Case of Metastatic Pancreatic Adenocarcinoma in Complete Remission Using Chemotherapy and Immunotherapy.
Among the various types of cancer, pancreatic cancer is considered to have a particularly grim prognosis. Treatment includes surgery, chemotherapy, or both. While the role of immunotherapy is well-studied in many ... | Recovered | ReactionOutcome | CC BY | 33728149 | 19,060,614 | 2021-02-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Antineutrophil cytoplasmic antibody'. | A Curious Case of Acute Glomerulonephritis - Staphylococcus vs Lupus: Case Report and Literature Review.
Here we report a case of a 65-year-old female, where we encountered acute glomerulonephritis. The patient initially presented with a hemorrhagic blister involving the second through fourth toes with serosanguinous d... | HYDRALAZINE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33728152 | 19,089,276 | 2021-02-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Glomerulonephritis rapidly progressive'. | A Curious Case of Acute Glomerulonephritis - Staphylococcus vs Lupus: Case Report and Literature Review.
Here we report a case of a 65-year-old female, where we encountered acute glomerulonephritis. The patient initially presented with a hemorrhagic blister involving the second through fourth toes with serosanguinous d... | HYDRALAZINE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33728152 | 20,117,890 | 2021-02-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nephritis'. | A Curious Case of Acute Glomerulonephritis - Staphylococcus vs Lupus: Case Report and Literature Review.
Here we report a case of a 65-year-old female, where we encountered acute glomerulonephritis. The patient initially presented with a hemorrhagic blister involving the second through fourth toes with serosanguinous d... | HYDRALAZINE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33728152 | 19,089,276 | 2021-02-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vasculitis'. | A Curious Case of Acute Glomerulonephritis - Staphylococcus vs Lupus: Case Report and Literature Review.
Here we report a case of a 65-year-old female, where we encountered acute glomerulonephritis. The patient initially presented with a hemorrhagic blister involving the second through fourth toes with serosanguinous d... | HYDRALAZINE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33728152 | 19,089,276 | 2021-02-04 |
What was the outcome of reaction 'Antineutrophil cytoplasmic antibody'? | A Curious Case of Acute Glomerulonephritis - Staphylococcus vs Lupus: Case Report and Literature Review.
Here we report a case of a 65-year-old female, where we encountered acute glomerulonephritis. The patient initially presented with a hemorrhagic blister involving the second through fourth toes with serosanguinous d... | Recovering | ReactionOutcome | CC BY | 33728152 | 19,089,276 | 2021-02-04 |
What was the outcome of reaction 'Nephritis'? | A Curious Case of Acute Glomerulonephritis - Staphylococcus vs Lupus: Case Report and Literature Review.
Here we report a case of a 65-year-old female, where we encountered acute glomerulonephritis. The patient initially presented with a hemorrhagic blister involving the second through fourth toes with serosanguinous d... | Recovering | ReactionOutcome | CC BY | 33728152 | 19,089,276 | 2021-02-04 |
What was the outcome of reaction 'Vasculitis'? | A Curious Case of Acute Glomerulonephritis - Staphylococcus vs Lupus: Case Report and Literature Review.
Here we report a case of a 65-year-old female, where we encountered acute glomerulonephritis. The patient initially presented with a hemorrhagic blister involving the second through fourth toes with serosanguinous d... | Recovering | ReactionOutcome | CC BY | 33728152 | 19,089,276 | 2021-02-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neuropathy peripheral'. | Death and Rebirth of the Thalidomide Molecule: A Case of Thalidomide-Induced Sensory Neuropathy.
The thalidomide molecule is a remarkable molecule that exists in a racemic mixture of optical isomers. In the 1950s, due to its teratogenicity, the levorotatory isomer led to its dramatic downfall. However, the molecule wit... | AMLODIPINE BESYLATE, CYCLOPHOSPHAMIDE, DEXAMETHASONE, MELPHALAN, THALIDOMIDE | DrugsGivenReaction | CC BY | 33728154 | 19,072,931 | 2021-02-04 |
What was the administration route of drug 'THALIDOMIDE'? | Death and Rebirth of the Thalidomide Molecule: A Case of Thalidomide-Induced Sensory Neuropathy.
The thalidomide molecule is a remarkable molecule that exists in a racemic mixture of optical isomers. In the 1950s, due to its teratogenicity, the levorotatory isomer led to its dramatic downfall. However, the molecule wit... | Oral | DrugAdministrationRoute | CC BY | 33728154 | 19,072,931 | 2021-02-04 |
What was the outcome of reaction 'Neuropathy peripheral'? | Death and Rebirth of the Thalidomide Molecule: A Case of Thalidomide-Induced Sensory Neuropathy.
The thalidomide molecule is a remarkable molecule that exists in a racemic mixture of optical isomers. In the 1950s, due to its teratogenicity, the levorotatory isomer led to its dramatic downfall. However, the molecule wit... | Recovering | ReactionOutcome | CC BY | 33728154 | 19,072,931 | 2021-02-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Relapsing Candida parapsilosis Endocarditis With Septic Embolization: A Case Report.
Candida endocarditis is a rare infection that is becoming an emerging and growing health concern, especially among risk groups such as the elderly and the immunosuppressed. It is associated with high morbidity and mortality. Dilemmas a... | CASPOFUNGIN, FLUCONAZOLE, GENTAMICIN, RIFAMPIN, VANCOMYCIN | DrugsGivenReaction | CC BY | 33728162 | 15,739,818 | 2021-02-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug resistance'. | Relapsing Candida parapsilosis Endocarditis With Septic Embolization: A Case Report.
Candida endocarditis is a rare infection that is becoming an emerging and growing health concern, especially among risk groups such as the elderly and the immunosuppressed. It is associated with high morbidity and mortality. Dilemmas a... | CASPOFUNGIN, FLUCONAZOLE, GENTAMICIN, RIFAMPIN, VANCOMYCIN | DrugsGivenReaction | CC BY | 33728162 | 15,739,818 | 2021-02-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pathogen resistance'. | Relapsing Candida parapsilosis Endocarditis With Septic Embolization: A Case Report.
Candida endocarditis is a rare infection that is becoming an emerging and growing health concern, especially among risk groups such as the elderly and the immunosuppressed. It is associated with high morbidity and mortality. Dilemmas a... | CASPOFUNGIN, FLUCONAZOLE, GENTAMICIN, RIFAMPIN, VANCOMYCIN | DrugsGivenReaction | CC BY | 33728162 | 15,739,818 | 2021-02-05 |
What was the administration route of drug 'FLUCONAZOLE'? | Relapsing Candida parapsilosis Endocarditis With Septic Embolization: A Case Report.
Candida endocarditis is a rare infection that is becoming an emerging and growing health concern, especially among risk groups such as the elderly and the immunosuppressed. It is associated with high morbidity and mortality. Dilemmas a... | Oral | DrugAdministrationRoute | CC BY | 33728162 | 15,739,818 | 2021-02-05 |
What was the dosage of drug 'FLUCONAZOLE'? | Relapsing Candida parapsilosis Endocarditis With Septic Embolization: A Case Report.
Candida endocarditis is a rare infection that is becoming an emerging and growing health concern, especially among risk groups such as the elderly and the immunosuppressed. It is associated with high morbidity and mortality. Dilemmas a... | 12 MG/KG, DAILY | DrugDosageText | CC BY | 33728162 | 15,739,818 | 2021-02-05 |
What was the outcome of reaction 'Drug ineffective'? | Relapsing Candida parapsilosis Endocarditis With Septic Embolization: A Case Report.
Candida endocarditis is a rare infection that is becoming an emerging and growing health concern, especially among risk groups such as the elderly and the immunosuppressed. It is associated with high morbidity and mortality. Dilemmas a... | Fatal | ReactionOutcome | CC BY | 33728162 | 15,739,818 | 2021-02-05 |
What was the outcome of reaction 'Drug resistance'? | Relapsing Candida parapsilosis Endocarditis With Septic Embolization: A Case Report.
Candida endocarditis is a rare infection that is becoming an emerging and growing health concern, especially among risk groups such as the elderly and the immunosuppressed. It is associated with high morbidity and mortality. Dilemmas a... | Fatal | ReactionOutcome | CC BY | 33728162 | 15,739,818 | 2021-02-05 |
What was the outcome of reaction 'Pathogen resistance'? | Relapsing Candida parapsilosis Endocarditis With Septic Embolization: A Case Report.
Candida endocarditis is a rare infection that is becoming an emerging and growing health concern, especially among risk groups such as the elderly and the immunosuppressed. It is associated with high morbidity and mortality. Dilemmas a... | Fatal | ReactionOutcome | CC BY | 33728162 | 15,739,818 | 2021-02-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myelosuppression'. | Metastatic thymic-enteric adenocarcinoma responding to chemoradiation plus anti-angiogenic therapy: A case report.
BACKGROUND
Thymic-enteric adenocarcinoma with positive expression of CDX2 and CK20 is rare in adults, with only 16 reported cases. However, standard treatment options for this type of thymic adenocarcinoma... | APATINIB, CAPECITABINE, OXALIPLATIN | DrugsGivenReaction | CC BY-NC | 33728312 | 19,075,475 | 2021-03-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Oesophagitis'. | Metastatic thymic-enteric adenocarcinoma responding to chemoradiation plus anti-angiogenic therapy: A case report.
BACKGROUND
Thymic-enteric adenocarcinoma with positive expression of CDX2 and CK20 is rare in adults, with only 16 reported cases. However, standard treatment options for this type of thymic adenocarcinoma... | APATINIB, CAPECITABINE, OXALIPLATIN | DrugsGivenReaction | CC BY-NC | 33728312 | 19,075,475 | 2021-03-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Radiation oesophagitis'. | Metastatic thymic-enteric adenocarcinoma responding to chemoradiation plus anti-angiogenic therapy: A case report.
BACKGROUND
Thymic-enteric adenocarcinoma with positive expression of CDX2 and CK20 is rare in adults, with only 16 reported cases. However, standard treatment options for this type of thymic adenocarcinoma... | APATINIB, CAPECITABINE, OXALIPLATIN | DrugsGivenReaction | CC BY-NC | 33728312 | 19,055,703 | 2021-03-06 |
What was the dosage of drug 'OXALIPLATIN'? | Metastatic thymic-enteric adenocarcinoma responding to chemoradiation plus anti-angiogenic therapy: A case report.
BACKGROUND
Thymic-enteric adenocarcinoma with positive expression of CDX2 and CK20 is rare in adults, with only 16 reported cases. However, standard treatment options for this type of thymic adenocarcinoma... | DAY 1 | DrugDosageText | CC BY-NC | 33728312 | 19,075,475 | 2021-03-06 |
What was the administration route of drug 'PENICILLIN G'? | Vancomycin-induced thrombocytopenia in endocarditis: A case report and review of literature.
BACKGROUND
Thrombocytopenia is a serious complication in the medical practice of numerous drugs. Vancomycin is frequently used for the prophylaxis and treatment of suspected or identified methicillin-resistant positive infectio... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33728314 | 19,048,518 | 2021-03-06 |
What was the administration route of drug 'VANCOMYCIN HYDROCHLORIDE'? | Vancomycin-induced thrombocytopenia in endocarditis: A case report and review of literature.
BACKGROUND
Thrombocytopenia is a serious complication in the medical practice of numerous drugs. Vancomycin is frequently used for the prophylaxis and treatment of suspected or identified methicillin-resistant positive infectio... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33728314 | 19,048,518 | 2021-03-06 |
What was the administration route of drug 'VANCOMYCIN'? | Vancomycin-induced thrombocytopenia in endocarditis: A case report and review of literature.
BACKGROUND
Thrombocytopenia is a serious complication in the medical practice of numerous drugs. Vancomycin is frequently used for the prophylaxis and treatment of suspected or identified methicillin-resistant positive infectio... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33728314 | 19,089,446 | 2021-03-06 |
What was the outcome of reaction 'Haemoglobin decreased'? | Vancomycin-induced thrombocytopenia in endocarditis: A case report and review of literature.
BACKGROUND
Thrombocytopenia is a serious complication in the medical practice of numerous drugs. Vancomycin is frequently used for the prophylaxis and treatment of suspected or identified methicillin-resistant positive infectio... | Recovered | ReactionOutcome | CC BY-NC | 33728314 | 19,048,518 | 2021-03-06 |
What was the outcome of reaction 'Thrombocytopenia'? | Vancomycin-induced thrombocytopenia in endocarditis: A case report and review of literature.
BACKGROUND
Thrombocytopenia is a serious complication in the medical practice of numerous drugs. Vancomycin is frequently used for the prophylaxis and treatment of suspected or identified methicillin-resistant positive infectio... | Recovered | ReactionOutcome | CC BY-NC | 33728314 | 19,048,518 | 2021-03-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug eruption'. | Peripherally Inserted Central Catheter-Associated Nocardia nova Endocarditis in a Patient Receiving Intravenous Antibiotics for Chronic Lyme Disease.
Long-term antibiotics are not effective for the therapy of patients with persistent symptoms and a history of Lyme disease. However, some clinicians still prescribe these... | AMIKACIN, AZITHROMYCIN ANHYDROUS, CEFTRIAXONE, DISULFIRAM, DOXYCYCLINE, SULFAMETHOXAZOLE\TRIMETHOPRIM | DrugsGivenReaction | CC BY-NC-ND | 33728358 | 19,724,199 | 2021-03 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.